Mono Pharmacare P/E Ratio

Current P/E Ratio
25.0
High Valuation
High - Growth expectations or overvalued

Mono Pharmacare P/E ratio. Mono Pharmacare (MONOPHARMA) P/E ratio is 25.0 (High), EPS (TTM) ₹0.41, current price ₹ on None — High - Growth expectations or overvalued. Check Mono Pharmacare marketcap in USD to track the company's total market size over time.

Current Valuation Metrics

P/E Ratio 25.0
Current Price ₹
EPS (TTM) ₹0.41
Exchange None

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 52.3
Sector Median 29.6
Sector Rank #11 of 255
Sector Percentile 4.3%

MONOPHARMA P/E Ratio — Valuation Signal & Historical Context

Mono Pharmacare P/E 25.0 — signal: Overvalued. Also explore MONOPHARMA price trends to track price trends across different timeframes.

  • Stock appears overvalued with PE of 25.0, suggesting caution for new investments
  • Trading at discount to sector average PE of 52.3

MONOPHARMA vs Healthcare Peers — P/E Ratio Comparison

Mono Pharmacare P/E 25.0 vs Healthcare average 52.3, median 29.6 — range 2.0–733.0.

Sector Average
52.3
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low